BIOMEDevice San Jose is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech Startups Compete at BIOMEDevice San Jose

Silicon Valley is synonymous with startups, so it's no surprise that the region is home to hundreds of businesses innovating in the medtech space. Companies like AtaCor, Medable Sana, and Health ZetaGen Therapeutics based in the region have made it on lists like "25 Medtech Startups You Need to Know."

From apps to wearables, diagnostic tools to minimally invasive surgical devices, innovation in healthcare technology is growing at a compound annual growth rate of 4.5%, on pace to reach a market value of $409.5 billion by 2023. And more specifically, medical startups in 2018 raised $9.5 billion in funding — no small feat considering the path is filled with hurdles like getting approval from insurance companies, government agencies, and other regulatory bodies.

New this year, BIOMEDevice San Jose presents its first Startup Showcase, a product presentation and pitch competition featuring some of the best startups in California. Learn about innovations spanning startup funding stages and hear from the entrepreneurs who are changing the future of healthcare.

Winners of the juried competition will receive a prize package from Informa.

Meet the Competitors:

A&W Engineering Works
A&W's mission is to develop innovative medical devices. We develop the entire system from front-end sensor to back-end application, and the entire analog, digital signal processing, and algorithmic data and control paths in between. Our team has expertise in hardware and software specific to medical devices that runs both deep and wide. We tackle hard to solve medical problems by bringing unique innovative development techniques for fast prototyping to deliver a quick proof of concept, all the while preparing the underlying path to production. Learn more at

AddiFab ApS
AddiFab is enabling injection molders to do short-series injection molding with the lead-times, start-up costs and design freedom known from 3D-printing.

Freeform Injection Molding (FIM) - our proprietary platform - exploits the core strengths of Additive Manufacturing to deliver breakthrough launch-time compression at breakthrough costs.

Our aim is to deliver agile hardware manufacturing solutions that help companies leapfrog prototyping and develop next-day products: launch-grade from the first iteration. Learn more at

Chronus Health
Chronus Health is a medical diagnostic startup building an affordable, point of care blood testing device to accelerate medical decision making in multiple clinical settings. Learn more at

De Oro Devices
De Oro Devices is focused on improving the quality of life for those in need. Our first product, the NexStrideTM, is an assistive device for individuals with Parkinson’s disease who experience freezing of gait. Freezing of gait is one of the most common and most debilitating symptoms of Parkinson’s disease; it takes away people’s independence and greatly decreases quality of life. The NexStride is a small, portable device that attaches to any cane or walker and uses clinically proven sensory cues to help overcome freezing of gait. It is composed of a visual cue (a green laser line) and an audio cue (a metronome). There is currently no effective solution to freezing of gait that is compatible with any cane or walker. De Oro Devices’ mission is to produce a line of products that can help individuals improve their quality of life. Learn more at

HeartBeam, Inc.
Branislav Vajdic, PhD is our CEO / Founder. An Intel Corp veteran who is credited to be the inventor / co-inventor of Intel's Flash Memory Technology and managed many successful iterations of Intel's Pentium CPU launches. Branislav also founded iCardio a company that went public and was sold. This venture called HeartBeam Inc has invented and developed technology that goes well beyond medical value. Heart disease is still #1 cause of death in the US and worldwide. In the developed world well informed aging and high risk population lives in constant fear of heart disease. Our technology can significantly decrease the fear and anxiety as it puts a powerful, always available "iCardiologist" in people's pockets. Indeed timely detection and intervention offered by our technology will make a dent in the survival rate and quality of life of pre and post intervention cardiac patients. In the developing world it can offer an inexpensive and highly accurate diagnostic tool to the population that had little or no access to cardiac diagnostic triage and diagnosis. Learn more at

Nasus Medical
Nasus Medical is developing a novel, solution to deliver steroids directly to the target anatomy implicated in Chronic Rhinosinusitis (CRS). This early intervention will enable patients to treat themselves at home, improving their quality of life, and avoiding unnecessary provider visits, medications, and procedures.

CRS affects 36 million patients in the US. The condition accounts for 1-2% of all physician visits and is associated with $7-12 billion in direct US health care costs per year. Nasal steroid sprays are typically prescribed as standard of care, but they are ineffective as they only reach the anterior portion of the nasal cavity. Maximal medical therapy fails in 50% of patients, leaving them with options of taking systemic drugs with serious side effects, having expensive, invasive procedures, or continuing to suffer without sufficient treatment. Learn more at

Oncodisc founders Dr. Andrew Thoreson and Dr. James Mitchell are physicians with over 15 years’ experience caring for cancer patients. Drs. Thoreson and Mitchell have prior startup experience developing vascular access devices including a successful technology sale to BD Bard. Rajan Patel, Oncodisc COO, brings over 30 years of experience developing medical devices, surgical tools, and drug delivery devices, including several startup exits. Theodore Johnson, MBA, is a medical device engineer with over 25 years of experience commercializing medical technology in large companies and startups. Learn more at

HiPic, Inc.
HiPic, Inc. was founded by a distinguished biomolecular professor who has received first place award from NIH in 2017 and a product development executive who has launched three product lines, each with over $1B/yr revenue. Learn more at

At Koya, we are developing the next-generation wearable therapeutic platform which offers compression anytime, anywhere. Compression therapy has wide-ranging applications from treating debilitating diseases such as chronic edema, Chronic Venous Insufficiency (CVI), Congestive Heart Failure (CHF), lymphedema, Deep-Vein Thrombosis (DVT), and post-surgical recovery. Today, the compression and edema market is estimated to be >$4B and growing at 7% CAGR. Existing solutions such as stockings, manual drainage, and Pneumatic Compression Devices (PCDs) are archaic and ineffective. PCDs are bulky, noisy, tethered, and difficult-to-use, yet they remain the standard-of-care for both home-health and hospital care. Our founding team has deep experience in successfully bringing value-based health technologies to market. Koya’s platform is based on advanced materials that allows electro-active compression to be weaved into clothing, making it a truly wearable therapeutic. This platform allows patient-specific patterned compression that is tailored, quiet, portable, and easy-to-wear. We are focused in developing the technology for treating edema with a sensor-based closed-loop system that can address the patient’s chronic needs. The device is IoT-enabled to remotely monitor and enable compliance. Our lean and hyper-efficient operating plan allows us to solve a large and growing unmet need. Learn more at

Lume Medical
Lume Medical is a minimally invasive medical device manufacturing company enabling improved vascular access and closure for trans-catheter therapies. We provide an integrated access sheath and closure device based on a "no-touch" surgical predicate that maximizes post-operative vascular patency and leaves no intravascular foreign bodies behind. As transcatheter therapies emerge & thrive, Lume provides a modern option to case closure.

Pulson, Inc.
Pulson was founded by Dr. Jeffery Bleich and has spent the last several years in fundamental research of the phenomena of guided natural counterpulsation. Based on the established medical science of external counterpulsation (ECP) and intra-aortic balloon counterpulsation, Pulson uses the rhythmic contraction of skeletal muscles to provide the "counter-pump", and utilizes a sensor and software to guide the user to counterpulse naturally while walking or running. Learn more at